• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Hologic settles dispute with Fleet

Article

Hologic has reached a settlement in its two-year dispute with Fleet Business Credit regarding a Master Product Financing Agreement entered into in September 1996. Under the original agreement, Fleet acquired Hologic bone densitometry systems to lease to

Hologic has reached a settlement in its two-year dispute with Fleet Business Credit regarding a Master Product Financing Agreement entered into in September 1996. Under the original agreement, Fleet acquired Hologic bone densitometry systems to lease to physicians on a fee-per-scan basis throughout the U.S. During the course of this three-year deal, Hologic sold around $61 million of bone densitometers. Fleet, however, suffered substantial losses under the program and sought to shift losses to Hologic. The settlement agreement provides for all claims to be dismissed with prejudice, and for Hologic to repay Fleet $3.05 million: $1.5 million cash and a note for $1.55 million payable in three years. Certain fees collected from Fleet customers, including scan overages and excess pool deposits, will be counted against the money Hologic must repay Fleet. This credit could reduce the total due to Fleet in three years from $3.05 million to about $1 million.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.